[1]蒋文,周玉玲,张颜彦.创伤性脓毒症患者白细胞介素-35的表达及其与降钙素原、T细胞和预后的关系[J]. 中华医院感染学杂志,2019,29(16):2405-2409.
[2]明颖,闫妹姝,刘秋霞,等.血清PCT、IL-6与CRP对严重创伤致脓毒症预后的影响[J]. 现代医学,2019,47(5):543-547.
[3]付国俊.降钙素原在多发伤合并脓毒症患者中的预测价值[J]. 世界最新医学信息文摘,2018,18(95):31-32.
[4]De Oro N, Gauthreaux ME, Lamoureux J, et al. The Use of Procalcitonin as a Sepsis Marker in aCommunity Hospital[J]. J Appl Lab Med,2019,3(4):545-552.
[5]Turhal G, Eraslan S, Kaya í,et al.Procalcitonin Levels in Chronic Rhinosinusitis[J]. Turk Arch Otorhinolaryngol,2019,57(3):113-116.
[6]Sharma S,Duggal N.Role of procalcitonin, Il-6 and C- reactive protein in suspected cases of sepsis[J]. Indian J Pathol Microbiol,2019,62(4):578-581.
[7]肖登峰.动态监测血清降钙素原在评估ICU脓毒症患者预后与严重程度中的价值[J]. 中国全科医学,2017,20(S1):8-11.
[8]Alshawawreh F,Lisi F,Ariotti N,et al.The use of a personal glucose meter for detecting procalcitonin through glucose encapsulated within liposomes[J]. Analyst,2019,144(21):6225-6230.
[9]Wang HD. Predictive value of serum procalcitonin and hypersensitive C-reactive protein levels in patients with acute cerebral infarction complicated with infection[J]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,2019,31(8):962-966.
[10]Kostic I.Gurrieri C.Piva E,et al.Comparison of Presepsin, Procalcitonin, Interleukin-8 and C-Reactive Protein in Predicting Bacteraemia in Febrile Neutropenic Adult Patients with Haematological Malignancies[J]. Mediterr J Hematol Infect Dis,2019,11(1):e2019047. doi: 10.4084/MJHID.2019.047.
[11]Venugopalan DP,Pillai G,Krishnan S.Diagnostic Value and Prognostic Use of PresepsinVersusProcalcitonin in Sepsis[J]. Cureus,2019,11(7):e5151. doi: 10.7759/cureus.5151.
[12]Voermans AM,Mewes JC,Broyles MR,et al.Cost-Effectiveness Analysis of a Procalcitonin-Guided Decision Algorithm for Antibiotic Stewardship Using Real-World U.S. Hospital Data[J]. OMICS,2019,23(10):508-515.
[13]李洪祥. C-反应蛋白、降钙素原与脓毒症的诊断及指导抗生素治疗的临床研究[D]. 长春:吉林大学,2015.
[1]张 丽,侯毅翰,张民伟,等.降钙素原在血流感染中的临床应用分析[J].医学研究与战创伤救治(原医学研究生学报),2013,15(06):603.[doi:10.3969/j.issn.1672-271X.2013.06.016]
ZHANG Li,HOU Yi-han,ZHANG Min-wei,et al.Cost-effective analysis of procalcitonin in the diagnosis of bloodstream infection[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2013,15(4):603.[doi:10.3969/j.issn.1672-271X.2013.06.016]
[2]黄凤楼,刁孟元,钱海飞,等.降钙素原及内毒素对腹腔感染脓毒症患者预后的评估[J].医学研究与战创伤救治(原医学研究生学报),2014,16(02):147.[doi:10.3969/j.issn.1672-271X.2014.02.011]
HUANG Feng-lou,DIAO Meng-yuan,QIAN Hai-fei,et al.Prognostic value of procalcitonin and endotoxin concentrations for intra-abdominal sepsis[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2014,16(4):147.[doi:10.3969/j.issn.1672-271X.2014.02.011]
[3]刘 瑜,方 放,黄 方.糖皮质激素受体基因多态性与脓毒症临床转归的相关性研究[J].医学研究与战创伤救治(原医学研究生学报),2015,17(06):575.[doi:10.3969/j.issn.1672-271X.2015.06.005]
LIU Yu,FANG Fang,HUANG Fang..Association of polymorphisms in glucocorticoid receptor with outcome of sepsis in a Chinese Han population[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2015,17(4):575.[doi:10.3969/j.issn.1672-271X.2015.06.005]
[4]郭剑,雷洁洁,章柏平,等.脓毒症患者连续性肾替代治疗时机选择及预后比较[J].医学研究与战创伤救治(原医学研究生学报),2018,20(01):37.[doi:10.3969/j.issn.1672-271X.2018.01.008]
GUO Jian,LEI Jie-jie,ZHANG Bo-ping,et al.Comparison of timing and prognosis of continuous renal replacement therapy in patients with sepsis[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2018,20(4):37.[doi:10.3969/j.issn.1672-271X.2018.01.008]
[5]窦燕,郭以河,孔晓飞,等.创伤弧菌脓毒症1例报道并文献复习[J].医学研究与战创伤救治(原医学研究生学报),2018,20(01):76.[doi:10.3969/j.issn.1672-271X.2018.01.018]
[6]李勇,宋薇.连续性血液净化联合益气活血法对脓毒症伴心肌功能障碍患者的临床疗效观察[J].医学研究与战创伤救治(原医学研究生学报),2018,20(03):225.[doi:10.3969/j.issn.1672-271X.2018.03.001]
LI Yong,SONG Wei.The clinical efficacy of continuous blood purification combined with Yiqi Huoxue for the sepsis patients with myocardial dysfunction[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2018,20(4):225.[doi:10.3969/j.issn.1672-271X.2018.03.001]
[7]林青伟,宋景春,曾庆波,等.大黄素对脓毒症大鼠凝血紊乱治疗的作用[J].医学研究与战创伤救治(原医学研究生学报),2018,20(05):464.[doi:10.3969/j.issn.1672-271X.2018.05.004]
LIN Qing-wei,SONG Jing-chun,ZENG Qing-bo,et al.Effect ofemodin on coagulation disorders of septic rats[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2018,20(4):464.[doi:10.3969/j.issn.1672-271X.2018.05.004]
[8]谢醒文,杨振宁,葛鑫,等.脓毒症相关凝血功能障碍对脓毒症患者预后的评估价值[J].医学研究与战创伤救治(原医学研究生学报),2020,22(2):161.[doi:10.3969/j.issn.1672-271X.2020.02.011]
XIE Xing wen,YANG Zhen ning,GE Xin,et al.A clinical research on relationship between sepsisassociated coagulopathy and prognosis in patients with sepsis[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2020,22(4):161.[doi:10.3969/j.issn.1672-271X.2020.02.011]
[9]钟林翠,宋景春,姜峻,等.血小板聚集率在评价脓毒症患者血小板功能及预后中的价值[J].医学研究与战创伤救治(原医学研究生学报),2020,22(3):249.[doi:10.3969/j.issn.1672-271X.2020.03.006]
ZHONG Lin-cui,SONG Jing-chun,JIANG Jun,et al.Clinical study on platelet aggregation to evaluate platelet function and prognosis in patients with sepsis[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2020,22(4):249.[doi:10.3969/j.issn.1672-271X.2020.03.006]
[10]曾庆波,宋景春,钟林翠,等.严重创伤与脓毒症患者凝血功能紊乱的比较研究[J].医学研究与战创伤救治(原医学研究生学报),2020,22(4):367.[doi:10.3969/j.issn.1672-271X.2020.04.007]
ZENG Qing-bo,SONG Jing-chun,ZHONG Lin-cui,et al.Comparation of coagulation dysfunction between severe trauma and sepsis patients[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2020,22(4):367.[doi:10.3969/j.issn.1672-271X.2020.04.007]